Marketing authorisation for a medicine Medical devices Application for general reimbursement Inspection of pharmaceutical companies Company authorisations and registrations DKMAnet Clinical trials of medicines Fees Product defects and withdrawals
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
Theme

Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

News and notifications

Updating of summaries of product characteristics due to changed ATC codes for 2026

05 January 2026

Marketing authorisation holders of medicinal products authorised under the national procedure, the decentralised procedure as well as the mutual recognition procedure should be aware that some ATC codes have been changed for 2026.

Danish Medicines Agency strengthens its organisational foundation to prepare for tomorrow's tasks

11 November 2025

Beware of websites and social media posts misusing the Danish Medi-cines Agency logo

21 August 2025

The Danish Medicines Agency requires bioequivalence data in a better data format

03 July 2025